We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+0.77%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$568M
AUM Growth
-$9.41M
Cap. Flow
+$1.58M
Cap. Flow %
0.28%
Top 10 Hldgs %
8.56%
Holding
680
New
121
Increased
206
Reduced
110
Closed
119

Top Buys

Rank Stock Value
1
RF icon
Regions Financial
RF
+$2.35M
2
EPAM icon
EPAM Systems
EPAM
+$2.11M
3
MET icon
MetLife
MET
+$2.08M
4
GPN icon
Global Payments
GPN
+$2.03M
5
CZR icon
Caesars Entertainment
CZR
+$2.02M

Top Sells

Rank Stock Value
1
FANG icon
Diamondback Energy
FANG
+$3.57M
2
KEY icon
KeyCorp
KEY
+$2.81M
3
TFC icon
Truist Financial
TFC
+$2.6M
4
TRV icon
Travelers Companies
TRV
+$2.57M
5
CTSH icon
Cognizant
CTSH
+$2.02M

Sector Composition

Rank Sector Weight
1 Financials 19.54%
2 Technology 15.74%
3 Healthcare 14.42%
4 Industrials 12.89%
5 Energy 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRX icon
501
Amneal Pharmaceuticals
AMRX
$5.71B
$208K 0.04%
149,516
SYF icon
502
Synchrony
SYF
$25.4B
$206K 0.04%
7,089
-350
-5% -$11.8K
IMGN
503
DELISTED
Immunogen Inc
IMGN
$205K 0.04%
53,313
+17,246
+48% +$73.5K
FAST icon
504
Fastenal
FAST
$59.8B
$205K 0.04%
+7,588
New +$195K
NUVB icon
505
Nuvation Bio
NUVB
$2.32B
$198K 0.03%
119,285
EQRX
506
DELISTED
EQRx, Inc. Common Stock
EQRX
$196K 0.03%
101,072
-4,526
-4% -$10.3K
LONA
507
LeonaBio Inc
LONA
$70.5M
$188K 0.03%
+7,525
New +$242K
NGM
508
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$188K 0.03%
46,062
IPSC icon
509
Century Therapeutics
IPSC
$357M
$181K 0.03%
+52,175
New +$229K
OLMA icon
510
Olema Pharmaceuticals
OLMA
$1.04B
$177K 0.03%
51,152
JNCE
511
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$175K 0.03%
94,783
MRSN
512
DELISTED
Mersana Therapeutics
MRSN
$175K 0.03%
1,705
ANNX icon
513
Annexon
ANNX
$883M
$173K 0.03%
45,057
+542
+1% +$2.98K
ITOS
514
DELISTED
iTeos Therapeutics
ITOS
$171K 0.03%
+12,557
New +$225K
NRIX icon
515
Nurix Therapeutics
NRIX
$2.69B
$167K 0.03%
18,756
MGTX icon
516
MeiraGTx Holdings
MGTX
$1.21B
$166K 0.03%
32,203
+5,256
+20% +$36.4K
STRO icon
517
Sutro Biopharma
STRO
$423M
$166K 0.03%
3,601
+25
+0.7% +$1.59K
ERAS icon
518
Erasca
ERAS
$6.29B
$166K 0.03%
55,066
BCAB icon
519
BioAtla
BCAB
$5.76M
$165K 0.03%
1,231
+580
+89% +$104K
CGEM icon
520
Cullinan Oncology
CGEM
$1.18B
$163K 0.03%
15,939
LENZ
521
LENZ Therapeutics
LENZ
$168M
$163K 0.03%
9,490
FHTX icon
522
Foghorn Therapeutics
FHTX
$371M
$162K 0.03%
26,163
KLRS
523
Kalaris Therapeutics
KLRS
$93.7M
$156K 0.03%
1,717
SGMO
524
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$153K 0.03%
86,934
+19,024
+28% +$54.3K
CCCC icon
525
C4 Therapeutics
CCCC
$400M
$151K 0.03%
48,047
+21,756
+83% +$128K

Similar funds

Cornercap Investment Counsel's Q1 2023 Portfolio in Review

As of Q1 2023, Cornercap Investment Counsel held 680 positions worth $568M, down 1.6% from $578M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Cornercap Investment Counsel's Q1 2023 filing shows 121 new, 206 increased, 110 reduced and 119 closed positions. Its largest new stake was Regions Financial: 108,036 shares worth $2.01M. The largest sale was Diamondback Energy, an estimated $3.57M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Cornercap Investment Counsel's largest Q1 2023 buy was Regions Financial: 108,036 shares worth $2.01M.
  • Cornercap Investment Counsel added most to Cigna in Q1 2023, an estimated $1.93M increase.
  • Cornercap Investment Counsel's biggest Q1 2023 reduction was Diamondback Energy, cutting an estimated $3.57M.
  • Cornercap Investment Counsel fully exited KeyCorp in Q1 2023, selling an estimated $2.81M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.6% of its $568M portfolio in Q1 2023.
  • Cornercap Investment Counsel opened 121 new positions and closed 119 in Q1 2023.
  • Cornercap Investment Counsel's portfolio value fell 1.6% quarter-over-quarter to $568M.

Based on Cornercap Investment Counsel's 13F filing for Q1 2023, filed 11 May 2023.